NASDAQ:GDRX
GoodRx Holdings, Inc.
GoodRx Holdings, Inc.'s revenue grew 0.6% in fiscal 2025 to $796.9M while operating margin rose to 11.0%. Free cash flow was $164.4M, 20.6% of revenue, and the diluted share count fell 9.0%.Summary generated from GoodRx Holdings, Inc.'s SEC filings. Latest annual report filed Feb 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$796.9M
Revenue growth+0.6%
Revenue, 5-yr CAGR+7.7%
Gross marginn/a
Operating margin11.0%
Net margin3.8%
ROIC5.8%
Return on equity4.5%
Debt / equity0.80
Free cash flow$164.4M
FCF margin20.6%
Share count change−9.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 745 | 767 | 750 | 792 | 797 |
| Operating income | 13 | 2 | −27 | 66 | 87 |
| Net income | −25 | −33 | −9 | 16 | 30 |
| Free cash flow | 174 | 143 | 137 | 183 | 164 |
Recent filings
- 4Insider transaction report
Sep 15, 2026 - 4Insider transaction report
Sep 15, 2026 - 8-KDirector or officer change
Aug 5, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 5, 2026 - 8-KResults of a shareholder vote
Jun 18, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 6, 2026 - 8-KResults of operations and financial condition
May 6, 2026